These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37574645)

  • 1. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis.
    Karamouzian M; Rafat B; Kolla G; Urbanoski K; Atkinson K; Bardwell G; Bonn M; Touesnard N; Henderson N; Bowles J; Boyd J; Brunelle C; Eeuwes J; Fikowski J; Gomes T; Guta A; Hyshka E; Ivsins A; Kennedy MC; Laurence G; Martignetti L; Nafeh F; Salters K; Tu D; Strike C; Pauly B; Werb D
    Int J Drug Policy; 2023 Oct; 120():104157. PubMed ID: 37574645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
    Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis.
    Kolla G; Pauly B; Cameron F; Hobbs H; Ranger C; McCall J; Majalahti J; Toombs K; LeMaistre J; Selfridge M; Urbanoski K
    Harm Reduct J; 2024 Jun; 21(1):111. PubMed ID: 38849866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'I don't chase drugs as much anymore, and I'm not dead': Client reported outcomes associated with safer opioid supply programs in Ontario, Canada.
    Schmidt RA; Kaminski N; Kryszajtys DT; Rudzinski K; Perri M; Guta A; Benoit AC; Bayoumi AM; Challacombe L; Hales J; Kenny K; Kolla G; O'Reilly E; Sereda A; Rai N; Strike C
    Drug Alcohol Rev; 2023 Nov; 42(7):1825-1837. PubMed ID: 37718646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.
    Pauly BB; Kurz M; Dale LM; Macevicius C; Kalicum J; Pérez DG; McCall J; Urbanoski K; Barker B; Slaunwhite A; Lindsay M; Nosyk B
    J Subst Use Addict Treat; 2024 Jun; 161():209341. PubMed ID: 38490334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation.
    McCall J; Hobbs H; Ranger C; Cameron F; Stuart H; Nelken J; Majalahti J; Urbanoski K; Kolla G; LeMaistre J; Toombs K; Herriot R; Pauly B
    Subst Abuse Treat Prev Policy; 2024 Mar; 19(1):19. PubMed ID: 38444035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
    Glegg S; McCrae K; Kolla G; Touesnard N; Turnbull J; Brothers TD; Brar R; Sutherland C; Le Foll B; Sereda A; Goyer MÈ; Rai N; Bernstein S; Fairbairn N
    Int J Drug Policy; 2022 Aug; 106():103742. PubMed ID: 35679695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada.
    Gagnon M; Rudzinski K; Guta A; Schmidt RA; Kryszajtys DT; Kolla G; Strike C
    Harm Reduct J; 2023 Jun; 20(1):81. PubMed ID: 37380995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safer opioid supply: qualitative program evaluation.
    Haines M; O'Byrne P
    Harm Reduct J; 2023 Apr; 20(1):53. PubMed ID: 37081500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
    Palis H; Haywood B; McDougall J; Xavier CG; Desai R; Tobias S; Burgess H; Ferguson M; Liu L; Kinniburgh B; Slaunwhite AK; Crabtree A; Buxton JA
    Harm Reduct J; 2024 Jan; 21(1):5. PubMed ID: 38184576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
    Kolla G; Tarannum CN; Fajber K; Worku F; Norris K; Long C; Fagundes R; Rucchetto A; Hannan E; Kikot R; Klaiman M; Firestone M; Bayoumi A; Laurence G; Hayman K
    Harm Reduct J; 2024 Jan; 21(1):17. PubMed ID: 38243267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study.
    Coulaud PJ; Chayama KL; Schwartz C; Purdie A; Lysyshyn M; Ti L; Knight R
    Harm Reduct J; 2024 Apr; 21(1):87. PubMed ID: 38678256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping a moral panic: News media narratives and medical expertise in public debates on safer supply, diversion, and youth drug use in Canada.
    Michaud L; Kolla G; Rudzinski K; Guta A
    Int J Drug Policy; 2024 May; 127():104423. PubMed ID: 38642543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces.
    Morris H; Bwala H; Wesley J; Hyshka E
    Can J Public Health; 2023 Jun; 114(3):484-492. PubMed ID: 36689127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of physician networks on the implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia.
    Kurz M; Guerra-Alejos BC; Min JE; Barker B; Pauly B; Urbanoski K; Nosyk B
    Implement Sci; 2024 Jan; 19(1):3. PubMed ID: 38184548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Safer Drug Supply" Measures in Canada to Reduce the Drug Overdose Fatality Toll: Clarifying Concepts, Practices and Evidence Within a Public Health Intervention Framework.
    Fischer B; Robinson T
    J Stud Alcohol Drugs; 2023 Nov; 84(6):801-807. PubMed ID: 37796625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.